Home / Insights / Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

Read the full article: Australian Financial Review

17 April 2026

Posted in — Growth Credit, News

Share
Share

You may also like

17 April 2026

OneVentures

Meet the women steering Australia’s high-tech future


12 January 2026

Healthcare

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO


15 October 2025

Growth Equity

Accel-KKR Acquires Phocas Software


View All

Ventured. Gained.
decor